BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Pfizer Stock Surges After Trump Deal on Drug Pricing and Tariff Exemption
Pfizer Stock Surges After Trump Deal on Drug Pricing and Tariff Exemption
12
3
BTCCSquare news:
Pfizer shares rallied more than 6% to $25 following an agreement with the TRUMP administration to reduce prices on key medications. The pharmaceutical giant secured a three-year exemption from recent industry tariffs while committing to Medicaid pricing reforms.
The 'TrumpRx' platform will serve as a direct-to-consumer portal for discounted pharmaceuticals, with some drugs seeing price cuts exceeding 50%. Market reaction was immediate, with PFE outperforming broader indices on the news.
By:
